Evidence map›Paper›PMID 39944114›Full record

ArticleDigital health

Focus groups on digital cognitive assessment in the context of Alzheimer's disease.

Sophie M van der Landen, Rosanne L van den Berg, Matthijs J Keijzer, Mariska N van Liere, Casper de Boer, Leonie N C Visser, Wiesje M van der Flier, Hanneke F M Rhodius-Meester, Sietske A M Sikkes

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sophie M van der LandenAlzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.ORCID https://orcid.org/0009-0007-6844-0861
Rosanne L van den BergAlzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.ORCID https://orcid.org/0009-0008-0685-9074
Matthijs J KeijzerAlzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Mariska N van LiereAlzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Casper de BoerAlzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Leonie N C VisserAlzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Wiesje M van der FlierAlzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Hanneke F M Rhodius-MeesterAlzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Sietske A M SikkesAlzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Digital cognitive assessments (DCAs) may facilitate early recognition of cognitive decline in the context of Alzheimer's disease (AD). While DCAs are increasingly emerging, they are often not used in practice. We assessed facilitators and barriers of using DCAs according to older individuals and patients. Methods: In five focus groups, we presented three different DCAs to older individuals with unimpaired cognition ( Results: Three main themes were identified: (1) test motivation ('Do I want to know my brain health?'), facilitated by early disease recognition, while impeded by fear of dementia; (2) digital test suitability ('Do I want to use a Discussion: Participants recognized the added value of DCAs, and multiple factors were identified as facilitators and barriers for their use. Similar factors could be a barrier for one, yet facilitated others, underlining the need for a personalized approach. Strategies to minimize barriers and exploit facilitators would ultimately foster implementation.

Indexed as

Alzheimer's diseaseDigital cognitive assessmentearly disease detectionend user perspectivesfocus groupspatient perspectives

Identifiers

PMID39944114
PMCPMC11815793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.